Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone as an Adjunct to CBT for Cocaine Relapse Prevention
NCT04843046Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Aug 2021
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in cocaine use disorder (CUD), sponsored by UTHealth Houston. Started Aug 2021; status: completed.
02
Drugs
pioglitazone
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT04843046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04843046.